Literature DB >> 7463235

Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children.

R E Kauffman, J N Miceli, L Strebel, J A Buckley, A K Done, A S Dajani.   

Abstract

The metabolism and elimination of chloramphenicol-3-monosuccinate was studied in 45 infants and children, ages 3 days to 16 years, during intravenous administration. The apparent half-life of chloramphenicol was extremely variable, ranging from 1.7 to 12.0 hours with a mean of 5.1 hours. Apparent half-lives were inversely correlated with age. Chloramphenicol-S serum concentration declined biexponentially in most patients, with an estimated mean initial half-life of 0.7 hours and a subsequent longer mean half-life of 2.2 hours. Chloramphenicol-S persisted in serum up to six hours after a dose, and comprised a significantly larger fraction of total chloramphenicol in the serum of infants under one month of age than in older infants and children. A widely variable fraction of the administered chloramphenicol-S dose, with a mean of 33%, was excreted in the urine unchanged and was, therefore, not bioavailable in active form. Mean renal clearance of chloramphenicol-S was 259.5 ml/minute/1.73 M2, four times the mean creatinine clearance, indicating active tubular secretion. Variable hydrolysis and renal elimination of nonhydrolyzed chloramphenicol-S reduces the bioavailability of the antibiotic and appears to contribute substantially to the wide variation in apparent half-life and poor correlation between dose and serum concentration of free chloramphenicol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7463235     DOI: 10.1016/s0022-3476(81)80670-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Neonatal pharmacology--a practical approach.

Authors:  D A MacKintosh
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

2.  Why still prescribe chloramphenicol in 1983? Comparison of the clinical and biological hematologic effects of chloramphenicol and thiamphenicol.

Authors:  E Baumelou; Y Najean
Journal:  Blut       Date:  1983-12

Review 3.  Chloramphenicol in the 1980s.

Authors:  I Shalit; M I Marks
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

6.  Comparison of ceftriaxone and traditional therapy of bacterial meningitis.

Authors:  B L Congeni
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

7.  Interaction between chloramphenicol and acetaminophen.

Authors:  J S Spika; D J Davis; S R Martin; K Beharry; J Rex; J V Aranda
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

8.  Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status.

Authors:  M Eriksson; L Paalzow; P Bolme; T W Mariam
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 9.  Pharmacokinetics of anti-infective agents in paediatric patients.

Authors:  D R Butler; R J Kuhn; M H Chandler
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

10.  Chloramphenicol clearance in typhoid fever: implications for therapy.

Authors:  Z A Bhutta; S K Niazi; A Suria
Journal:  Indian J Pediatr       Date:  1992 Mar-Apr       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.